RankAlpha logo
Back to Rankings

VCEL

VericelC
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
View Chart
+
Peers tracked
9
U.S. public peers
Grade Position
In line
vs peer average
VCEL vs peer average
46/100
VCEL vs. peer average (C vs. C)
Grade spread
A 2 · B 1 · C 3 · D 3
Graded peers loaded
Coverage
9 graded
100% of tracked

Peer overview

ANIP is the first available peer comparator.

ANI Pharmaceuticals is a closer small-cap specialty-pharma size comp than a business-line comp; it is useful mainly for small-cap biotech valuation context, not for cartilage repair or burn-care operating read-throughs.

Peer source comes from the stored AI memo or peer model
Grades and factor rows use RankAlpha API data when available
Missing peer scores remain blank instead of being estimated
Side-by-side comparison keeps the data contract visible
Top peerANIPANI
VCEL
Vericel
ANIP
ANI
Grade
C
B
Momentum
16
11
Value
60
69
Sentiment
58
77
Setup Bias
Net —
-
Market Cap
-
-
Posture
Mixed
Constructive

Grade position vs ANIP

VCEL / ANIP
Grade Position
In line
VCEL vs. peer average (C vs. C)
46/100
Momentum
16
VCEL
Value
60
ANIP
Sentiment
58
ANIP

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs VCEL
1
ANIP
ANIP
B
80/100
-1
2
HRMY
HRMY
A
100/100
-2
3
HCM
HUTCHMED (China) Ltd ADR
D
40/100
+1
4
ALMR
Alamar Biosciences Inc Common
C
60/100
Even
5
PVLA
Palvella Therapeutics Inc Common
D
40/100
+1
ANIP is the first peer returned for this comparison set.